Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2016 (2016), Article ID 5213628, 13 pages
http://dx.doi.org/10.1155/2016/5213628
Research Article

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies

1Translational Medicine and Diagnostics, Morphotek, Inc., Exton, PA 19341, USA
2M2Gen, Tampa, FL 33612, USA
3H. Lee Moffitt Cancer Center and Research Institute, Department of Biostatistics and Biostatistics, Tampa, FL 33612, USA
4Department of Bioinformatics, Virginia Commonwealth University, Richmond, VA 23284, USA
5Sarcoma Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
6Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
7Adolescent and Young Adult Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA

Received 9 November 2015; Accepted 30 December 2015

Academic Editor: C. Verhoef

Copyright © 2016 Daniel J. O’Shannessy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. J. Rettig, P. Garin-Chesa, J. H. Healey, S. L. Su, E. A. Jaffe, and L. J. Old, “Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 22, pp. 10832–10836, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Christian, H. Ahorn, A. Koehler et al., “Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium,” The Journal of Biological Chemistry, vol. 276, no. 10, pp. 7408–7414, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Feng, A. Mantesso, C. De Bari, A. Nishiyama, and P. T. Sharp, “Dual origin of mesenchymal stem cells contributing to organ growth and repair,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 16, pp. 6503–6508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Bergers and S. Song, “The role of pericytes in blood-vessel formation and maintenance,” Neuro-Oncology, vol. 7, no. 4, pp. 452–464, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. F. Olumi, G. D. Grossfeld, S. W. Hayward, P. R. Carroll, T. D. Tlsty, and G. R. Cunha, “Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium,” Cancer Research, vol. 59, no. 19, pp. 5002–5011, 1999. View at Google Scholar · View at Scopus
  6. V. Nehls and D. Drenckhahn, “The versatility of microvascular pericytes: from mesenchyme to smooth muscle?” Histochemistry, vol. 99, no. 1, pp. 1–12, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Lin, M. Garcia, H. Ning et al., “Defining stem and progenitor cells within adipose tissue,” Stem Cells and Development, vol. 17, no. 6, pp. 1053–1063, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Crisan, S. Yap, L. Casteilla et al., “A perivascular origin for mesenchymal stem cells in multiple human organs,” Cell Stem Cell, vol. 3, no. 3, pp. 301–313, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Alliot-Licht, D. Hurtrel, and M. Gregoire, “Characterization of α-smooth muscle actin positive cells in mineralized human dental pulp cultures,” Archives of Oral Biology, vol. 46, no. 3, pp. 221–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Shi and S. Gronthos, “Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp,” Journal of Bone and Mineral Research, vol. 18, no. 4, pp. 696–704, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Elenbaas and R. A. Weinberg, “Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation,” Experimental Cell Research, vol. 264, no. 1, pp. 169–184, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Montesano, G. Schaller, and L. Orci, “Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors,” Cell, vol. 66, no. 4, pp. 697–711, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. D. L. Hardie, M. J. Baldwin, A. Naylor et al., “The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation,” Immunology, vol. 133, no. 3, pp. 288–295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Forsberg, I. Valyi-Nagy, C.-H. Heldin, M. Herlyn, and B. Westermark, “Platelet-Derived Growth Factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 2, pp. 393–397, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Tomkowicz, K. Rybinski, D. Sebeck et al., “Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling,” Cancer Biology and Therapy, vol. 9, no. 11, pp. 908–915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Rmali, M. C. A. Puntis, and W. G. Jiang, “Prognostic values of tumor endothelial markers in patients with colorectal cancer,” World Journal of Gastroenterology, vol. 11, no. 9, pp. 1283–1286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. L. F. Brown, A. J. Guidi, S. J. Schnitt et al., “Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast,” Clinical Cancer Research, vol. 5, no. 5, pp. 1041–1056, 1999. View at Google Scholar · View at Scopus
  18. G. Davies, G. H. Cunnick, R. E. Mansel, M. D. Mason, and W. G. Jiang, “Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer,” Clinical and Experimental Metastasis, vol. 21, no. 1, pp. 31–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Dolznig, N. Schweifer, C. Puri et al., “Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin,” Cancer Immunity, vol. 5, article 10, 2005. View at Google Scholar · View at Scopus
  20. J. Brady, J. Neal, N. Sadakar, and P. Gasque, “Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 12, pp. 1274–1283, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. A. Huber, N. Kraut, N. Schweifer et al., “Expression of stromal cell markers in distinct compartments of human skin cancers,” Journal of Cutaneous Pathology, vol. 33, no. 2, pp. 145–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. A. Diaz Jr., C. M. Coughlin, S. C. Weil et al., “A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors,” Clinical Cancer Research, vol. 21, no. 6, pp. 1281–1288, 2015. View at Publisher · View at Google Scholar
  23. C. Rouleau, M. Curiel, W. Weber et al., “Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma,” Clinical Cancer Research, vol. 14, no. 22, pp. 7223–7236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Rouleau, R. Smale, Y.-S. Fu et al., “Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling,” International Journal of Oncology, vol. 39, no. 1, pp. 73–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Weiss, J. Gill, J. Goldberg et al., “Advances in therapy for pediatric sarcomas,” Current Oncology Reports, vol. 16, article 395, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. E. K. Amankwah, A. P. Conley, and D. R. Reed, “Epidemiology and therapies for metastatic sarcoma,” Clinical Epidemiology, vol. 5, no. 1, pp. 147–162, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Van Glabbeke, J. Verweij, I. Judson, and O. S. Nielsen, “Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas,” European Journal of Cancer, vol. 38, no. 4, pp. 543–549, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Fenstermacher, R. M. Wenham, D. E. Rollison, and W. S. Dalton, “Implementing personalized medicine in a cancer center,” Cancer Journal, vol. 17, no. 6, pp. 528–536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Kiyohara, N. Donovan, L. Takeshima et al., “Endosialin expression in metastatic melanoma tumor microenvironment vasculature: potential therapeutic implications,” Cancer Microenvironment, vol. 8, no. 2, pp. 111–118, 2015. View at Publisher · View at Google Scholar
  30. F. R. Hirsch, M. Varella-Garcia, P. A. Bunn Jr. et al., “Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis,” Journal of Clinical Oncology, vol. 21, no. 20, pp. 3798–3807, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Ishibashi, T. Suzuki, S. Suzuki et al., “Sex steroid hormone receptors in human thymoma,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2309–2317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Cronin, E. McAdam, A. Danikas et al., “Epidermal Growth Factor Receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's Esophagus (BE),” The American Journal of Gastroenterology, vol. 106, no. 1, pp. 46–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. A. Cohen, D. J. Dabbs, K. L. Cooper et al., “Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma,” American Journal of Clinical Pathology, vol. 138, no. 6, pp. 796–802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Pirker, J. R. Pereira, J. von Pawel et al., “EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study,” The Lancet Oncology, vol. 13, no. 1, pp. 33–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. A. Welsh, S. A. Eschrich, A. E. Berglund, and D. A. Fenstermacher, “Iterative rank-order normalization of gene expression microarray data,” BMC Bioinformatics, vol. 14, article 153, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. G. Facciponte, S. Ugel, F. De Sanctis et al., “Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature,” Journal of Clinical Investigation, vol. 124, no. 4, pp. 1497–1511, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Rouleau, J. Sancho, J. Campos-Rivera, and B. A. Teicher, “Endosialin expression in side populations in human sarcoma cell lines,” Oncology Letters, vol. 3, no. 2, pp. 325–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Tomkowicz, K. Rybinski, B. Foley et al., “Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 46, pp. 17965–17970, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Ohradanova, K. Gradin, M. Barathova et al., “Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2,” British Journal of Cancer, vol. 99, no. 8, pp. 1348–1356, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. H. F. Dvorak, “Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing,” The New England Journal of Medicine, vol. 315, no. 26, pp. 1650–1659, 1986. View at Publisher · View at Google Scholar · View at Scopus
  41. D. J. O'Shannessy, E. B. Somers, L. K. Chandrasekaran, N. C. Nicolaides, J. Bordeaux, and M. D. Gustavson, “Influence of tumor microenvironment on prognosis in colorectal cancer: tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins,” Oncotarget, vol. 5, no. 12, pp. 3983–3995, 2014. View at Publisher · View at Google Scholar · View at Scopus